A first healthy adults group has been dosed in an early clinical trial of an oral and myelin-protective treatment for all types of MS.

Increased production of cholesterol by stem cells in the brain contributes to neurological damage in multiple sclerosis, a ...

Higher blood levels of bile acids, molecules that aid fat absorption in the gut, are linked to slower MS progression, per ...

For columnist Susan Payrovi, music and dance are key to connecting with others and living a joyful life with multiple ...

Researchers found a molecule, sulfuretin, can promote myelin repair, slowing disease progression in MS and some cancers.

The prevalence of MS in Australia has been increasing at an accelerating rate in recent years, according to a report from MS ...

RRMS disability progression rates have decreased over the years due to advances in disease-modifying therapies (DMTs), per an ...

Activity of ancient viral genes may play a role in the development of multiple sclerosis (MS) and other neurological ...

A pair of Phase 3 trials testing vidofludimus calcium in relapsing MS are continuing as planned after a positive committee ...

Columnist Ben Hofmeister thinks multiple sclerosis would be a scary costume for Halloween. But just how could he dress up to render it?

Columnist Ben Hofmeister discusses the dual process model of coping and why allowing yourself to grieve can be part of a healthy process.

Developing a more comprehensive understanding of the interactions between the brain, blood vessels, and the immune system ...